Teva Pharmaceuticals International Gmbh v. Eli Lilly and Company
U.S. Court of Appeals for the Federal Circuit
Teva Pharmaceuticals International Gmbh v. Eli Lilly and Company
Opinion
Case: 24-1149 Document: 3 Page: 1 Filed: 09/08/2025
NOTE: This order is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
TEVA PHARMACEUTICALS INTERNATIONAL
GMBH, TEVA PHARMACEUTICALS USA, INC.,
Plaintiffs-Appellants
v.
ELI LILLY AND COMPANY,
Defendant-Cross-Appellant
______________________
2024-1094
______________________
Appeal from the United States District Court for the
District of Massachusetts in No. 1:18-cv-12029-ADB, Judge
Allison Dale Burroughs.
-------------------------------------------
TEVA PHARMACEUTICALS INTERNATIONAL
GMBH, TEVA PHARMACEUTICALS USA, INC.,
Plaintiffs-Appellants
v.
ELI LILLY AND COMPANY,
Defendant-Cross-Appellant
______________________
2024-1149
Case: 24-1149 Document: 3 Page: 2 Filed: 09/08/2025
2 TEVA PHARMACEUTICALS INTERNATIONAL GMBH v.
ELI LILLY AND COMPANY
______________________
Appeal from the United States District Court for the
District of Massachusetts in No. 1:18-cv-12029-ADB, Judge
Allison Dale Burroughs.
______________________
ORDER
Mylan Pharmaceuticals Inc. and Bausch Health Ire-
land Ltd stipulate to voluntary dismissal of Appeal No. 24-
1149.
The parties, having so agreed,
IT IS ORDERED THAT:
(1) Appeal No. 24-1149 is dismissed under Fed. R.
App. P. 42(b), with each side to bear their own costs.
(2) The official captions as modified, are reflected in
this order.
FOR THE COURT
September 8, 2025
Date
ISSUED AS A MANDATE (as to Appeal No. 24-1149
only): September 8, 2025.
Reference
- Status
- Unpublished